Every step of your journey, from the initial consultation to ongoing progress checks, is overseen by our qualified medical team
As the majority of patients with type 2 diabetes are overweight or obese this offers a potential advantage over older, established therapies, and DPP-4 inhibitors are being used in clinical practice as second-line therapy in addition to metformin in overweight and obese patients who fail to reach glycemic targets with metformin monotherapy
Expected timeline: Month 1: 4 to 8 pounds lost, primarily appetite-driven deficit Month 2 to 3: 2 to 4 pounds per week sustained loss Month 4 to 6: Continued loss with improved body composition from muscle preservation Protocol 4: the over-40 male optimization stack Goal: Address age-related metabolic slowdown and body composition changes Stack: Tesamorelin: 2mg nightly before bed CJC-1295/ipamorelin: 100mcg/100mcg nightly (can be combined in same injection as tesamorelin) MOTS-c: 10mg weekly Why this works: After 40, GH decline accelerates and mitochondrial function degrades
Regular communication with your healthcare provider, along with the use of reliable contraception, can help minimize these risks and provide clarity when needed
Rather than following standard titration protocols that push toward maximum doses, EllieMD providers may prescribe lower maintenance doses aimed at finding the minimum effective amount
- Route preference: Are regular injections feasible or is an oral option required